EE50 Olaparib As Maintenance Therapy for Women with Ovarian Cancer and Homologous Recombination Deficiency in Brazil: What Clinical and Cost Data Have Highest Impact on Cost-Effectiveness Analysis?
Abstract
Authors
L Okumura MH Massaoka I Areas C Licursi A Mihai J Ryan